Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Predictors of Mortality in a Clinic Cohort of HIV-1 Infected Children Initiated on Antiretroviral Therapy in Jos, Nigeria.

Ebonyi AO, Oguche S, Meloni ST, Sagay SA, Kyriacou DN, Achenbach CJ, Agbaji OO, Oyebode TA, Okonkwo P, Idoko JA, Kanki PJ.

J AIDS Clin Res. 2014;5(12). pii: 403. doi: 10.4172/2155-6113.1000403. Epub 2014 Dec 20.

PMID:
30416842
2.

Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis.

Grover S, Desir F, Jing Y, Bhatia RK, Trifiletti DM, Swisher-McClure S, Kobie J, Moore RD, Rabkin CS, Silverberg MJ, Salters K, Mathews WC, Gill MJ, Thorne JE, Castilho J, Kitahata MM, Justice A, Horberg MA, Achenbach CJ, Mayor AM, Althoff KN; North American AIDS Cohort Collaboration on Research and Design.

J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):421-429. doi: 10.1097/QAI.0000000000001842.

PMID:
30211722
3.

DNA Methylation of Telomere-Related Genes and Cancer Risk.

Joyce BT, Zheng Y, Nannini D, Zhang Z, Liu L, Gao T, Kocherginsky M, Murphy R, Yang H, Achenbach CJ, Roberts LR, Hoxha M, Shen J, Vokonas P, Schwartz J, Baccarelli A, Hou L.

Cancer Prev Res (Phila). 2018 Aug;11(8):511-522. doi: 10.1158/1940-6207.CAPR-17-0413. Epub 2018 Jun 12.

PMID:
29895583
4.

Promoter methylation of PGC1A and PGC1B predicts cancer incidence in a veteran cohort.

Kresovich JK, Joyce BT, Gao T, Zheng Y, Zhang Z, Achenbach CJ, Murphy RL, Just AC, Shen J, Yang H, Vokonas P, Schwartz J, Baccarelli AA, Hou L.

Epigenomics. 2018 Jun;10(6):733-743. doi: 10.2217/epi-2017-0141. Epub 2018 Jun 11.

PMID:
29888964
5.

Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy.

Lee JS, Cole SR, Achenbach CJ, Dittmer DP, Richardson DB, Miller WC, Mathews C, Althoff KN, Moore RD, Eron JJ Jr; Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS).

PLoS One. 2018 Jun 5;13(6):e0197665. doi: 10.1371/journal.pone.0197665. eCollection 2018.

6.

Atrial arrhythmia prevalence and characteristics for human immunodeficiency virus-infected persons and matched uninfected controls.

Sanders JM, Steverson AB, Pawlowski AE, Schneider D, Achenbach CJ, Lloyd-Jones DM, Feinstein MJ.

PLoS One. 2018 Mar 20;13(3):e0194754. doi: 10.1371/journal.pone.0194754. eCollection 2018.

7.

miRNA-Processing Gene Methylation and Cancer Risk.

Joyce BT, Zheng Y, Zhang Z, Liu L, Kocherginsky M, Murphy R, Achenbach CJ, Musa J, Wehbe F, Just A, Shen J, Vokonas P, Schwartz J, Baccarelli AA, Hou L.

Cancer Epidemiol Biomarkers Prev. 2018 May;27(5):550-557. doi: 10.1158/1055-9965.EPI-17-0849. Epub 2018 Feb 23.

PMID:
29475968
8.

Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, Mali.

Kone B, Sarro YS, Maiga M, Sanogo M, Somboro AM, Diarra B, Togo ACG, Coulibaly N, Dembele BPP, Goita D, Baya B, Kone A, Diabaté S, Polis MA, Belson M, Dao S, Orsega S, Achenbach CJ, Murphy RL, Diallo S, Siddiqui S.

Epidemiol Infect. 2018 Feb;146(3):354-358. doi: 10.1017/S0950268817003090. Epub 2018 Jan 15.

9.

Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature.

Silas OA, Achenbach CJ, Murphy RL, Hou L, Sagay SA, Banwat E, Adoga AA, Musa J, French DD.

Expert Rev Vaccines. 2018 Jan;17(1):91-98. doi: 10.1080/14760584.2018.1411195. Epub 2017 Dec 6. Review.

PMID:
29183182
10.

Clinical characteristics of HIV-infected patients with adjudicated heart failure.

Steverson AB, Pawlowski AE, Schneider D, Nannapaneni P, Sanders JM, Achenbach CJ, Shah SJ, Lloyd-Jones DM, Feinstein MJ.

Eur J Prev Cardiol. 2017 Nov;24(16):1746-1758. doi: 10.1177/2047487317732432. Epub 2017 Sep 25.

11.

Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.

Musa J, Achenbach CJ, O'Dwyer LC, Evans CT, McHugh M, Hou L, Simon MA, Murphy RL, Jordan N.

PLoS One. 2017 Sep 5;12(9):e0183924. doi: 10.1371/journal.pone.0183924. eCollection 2017. Review. Erratum in: PLoS One. 2017 Dec 29;12 (12 ):e0190661.

12.

Erratum to: Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.

Silas OA, Achenbach CJ, Hou L, Murphy RL, Egesie JO, Sagay SA, Agbaji OO, Agaba PA, Musa J, Manasseh AN, Jatau ED, Dauda AM, Akanbi MO, Mandong BM.

Infect Agent Cancer. 2017 Jun 26;12:37. doi: 10.1186/s13027-017-0149-2. eCollection 2017.

13.

Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation.

Lee JS, Cole SR, Richardson DB, Dittmer DP, Miller WC, Moore RD, Kitahata M, Mathews C, Mayer K, Geng E, Achenbach CJ, Eron JJ Jr; Center for AIDS Research Network of Integrated Clinical Systems.

AIDS. 2017 Sep 10;31(14):1989-1997. doi: 10.1097/QAD.0000000000001573.

14.

Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.

Silas OA, Achenbach CJ, Hou L, Murphy RL, Egesie JO, Sagay SA, Agbaji OO, Agaba PE, Musa J, Manasseh AN, Jatau ED, Dauda AM, Akanbi MO, Mandong BM.

Infect Agent Cancer. 2017 Jun 5;12:34. doi: 10.1186/s13027-017-0144-7. eCollection 2017. Erratum in: Infect Agent Cancer. 2017 Jun 26;12 :37.

15.

Statin Prescribing Practices in the Comprehensive Care for HIV-Infected Patients.

Kelly SG, Krueger KM, Grant JL, Penugonda S, Feinstein MJ, Taiwo BO, Achenbach CJ.

J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):e26-e29. doi: 10.1097/QAI.0000000000001454. No abstract available.

PMID:
28520617
16.

Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.

Dubrow R, Qin L, Lin H, Hernández-Ramírez RU, Neugebauer RS, Leyden W, Althoff KN, Achenbach CJ, Hessol NA, Modur SP, DʼSouza G, Bosch RJ, Grover S, Horberg MA, Kitahata MM, Mayor AM, Novak RM, Rabkin CS, Sterling TR, Goedert JJ, Justice AC, Engels EA, Moore RD, Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.

J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):382-390. doi: 10.1097/QAI.0000000000001394.

17.

Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.

Feinstein MJ, Nance RM, Drozd DR, Ning H, Delaney JA, Heckbert SR, Budoff MJ, Mathews WC, Kitahata MM, Saag MS, Eron JJ, Moore RD, Achenbach CJ, Lloyd-Jones DM, Crane HM.

JAMA Cardiol. 2017 Feb 1;2(2):155-162. doi: 10.1001/jamacardio.2016.4494.

18.

HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers.

Shiels MS, Althoff KN, Pfeiffer RM, Achenbach CJ, Abraham AG, Castilho J, Cescon A, D'Souza G, Dubrow R, Eron JJ, Gebo K, John Gill M, Goedert JJ, Grover S, Hessol NA, Justice A, Kitahata M, Mayor A, Moore RD, Napravnik S, Novak RM, Thorne JE, Silverberg MJ, Engels EA; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA).

Clin Infect Dis. 2017 Feb 15;64(4):468-475. doi: 10.1093/cid/ciw764.

19.

HIV-Related Myocardial Vulnerability to Infarction and Coronary Artery Disease.

Feinstein MJ, Mitter SS, Yadlapati A, Achenbach CJ, Palella FJ Jr, Gonzalez PE, Meyers S, Collins JD, Shah SJ, Lloyd-Jones DM.

J Am Coll Cardiol. 2016 Nov 1;68(18):2026-2027. doi: 10.1016/j.jacc.2016.07.771. No abstract available. Erratum in: J Am Coll Cardiol. 2016 Dec 27;68(25):2920.

20.

Differences by HIV serostatus in coronary artery disease severity and likelihood of percutaneous coronary intervention following stress testing.

Feinstein MJ, Poole B, Engel Gonzalez P, Pawlowski AE, Schneider D, Provias TS, Palella FJ, Achenbach CJ, Lloyd-Jones DM.

J Nucl Cardiol. 2018 Jun;25(3):872-883. doi: 10.1007/s12350-016-0689-7. Epub 2016 Oct 13.

21.

Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.

Yanik EL, Achenbach CJ, Gopal S, Coghill AE, Cole SR, Eron JJ, Moore RD, Mathews WC, Drozd DR, Hamdan A, Ballestas ME, Engels EA.

J Clin Oncol. 2016 Sep 20;34(27):3276-83. doi: 10.1200/JCO.2016.67.6999. Epub 2016 Aug 9.

22.

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects.

Gach JS, Gorlani A, Dotsey EY, Becerra JC, Anderson CT, Berzins B, Felgner PL, Forthal DN, Deeks SG, Wilkin TJ, Casazza JP, Koup RA, Katlama C, Autran B, Murphy RL, Achenbach CJ.

PLoS One. 2016 Aug 8;11(8):e0160341. doi: 10.1371/journal.pone.0160341. eCollection 2016.

23.

Cervical cancer survival in a resource-limited setting-North Central Nigeria.

Musa J, Nankat J, Achenbach CJ, Shambe IH, Taiwo BO, Mandong B, Daru PH, Murphy RL, Sagay AS.

Infect Agent Cancer. 2016 Mar 24;11:15. doi: 10.1186/s13027-016-0062-0. eCollection 2016.

24.

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial.

Katlama C, Lambert-Niclot S, Assoumou L, Papagno L, Lecardonnel F, Zoorob R, Tambussi G, Clotet B, Youle M, Achenbach CJ, Murphy RL, Calvez V, Costagliola D, Autran B; EraMune-01 study team.

AIDS. 2016 Jan;30(2):221-30. doi: 10.1097/QAD.0000000000000894.

PMID:
26684819
25.

Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.

Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D'Souza G, Engels EA, Hessol NA, Brooks JT, Burchell AN, Gill MJ, Goedert JJ, Hogg R, Horberg MA, Kirk GD, Kitahata MM, Korthuis PT, Mathews WC, Mayor A, Modur SP, Napravnik S, Novak RM, Patel P, Rachlis AR, Sterling TR, Willig JH, Justice AC, Moore RD, Dubrow R; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.

Ann Intern Med. 2015 Oct 6;163(7):507-18. doi: 10.7326/M14-2768.

26.

Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial.

Achenbach CJ, Assoumou L, Deeks SG, Wilkin TJ, Berzins B, Casazza JP, Lambert-Niclot S, Koup RA, Costagliola D, Calvez V, Katlama C, Autran B, Murphy RL; EraMune 02 study team.

Lancet HIV. 2015 Mar;2(3):e82-91. doi: 10.1016/S2352-3018(15)00026-0. Epub 2015 Feb 17.

PMID:
26424549
27.

HIV Associated Chronic Obstructive Pulmonary Disease in Nigeria.

Akanbi MO, Taiwo BO, Achenbach CJ, Ozoh OB, Obaseki DO, Sule H, Agbaji OO, Ukoli CO.

J AIDS Clin Res. 2015 May;6(5). pii: 453.

28.

A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens.

Dotsey EY, Gorlani A, Ingale S, Achenbach CJ, Forthal DN, Felgner PL, Gach JS.

PLoS One. 2015 May 4;10(5):e0125581. doi: 10.1371/journal.pone.0125581. eCollection 2015.

29.

A Systematic Review of the Usefulness of Statin Therapy in HIV-Infected Patients.

Feinstein MJ, Achenbach CJ, Stone NJ, Lloyd-Jones DM.

Am J Cardiol. 2015 Jun 15;115(12):1760-6. doi: 10.1016/j.amjcard.2015.03.025. Epub 2015 Mar 24. Review.

PMID:
25907504
30.

Reply to P. De Paoli et al.

Gopal S, Achenbach CJ, Yanik EL, Dittmer DP, Eron JJ, Engels EA.

J Clin Oncol. 2014 Sep 20;32(27):3079. No abstract available.

PMID:
25002715
31.

Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort.

Gopal S, Patel MR, Achenbach CJ, Yanik EL, Cole SR, Napravnik S, Burkholder GA, Mathews WC, Rodriguez B, Deeks SG, Mayer KH, Moore RD, Kitahata MM, Richards KL, Eron JJ.

Clin Infect Dis. 2014 Jul 15;59(2):279-86. doi: 10.1093/cid/ciu270. Epub 2014 Apr 21.

32.

Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.

Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Dittmer DP, Olshan AF, Kitahata MM, Mugavero MJ, Saag M, Moore RD, Mathews WC, Hunt P, Eron JJ.

AIDS. 2014 Apr 24;28(7):979-87. doi: 10.1097/QAD.0000000000000167.

33.

Moving forward in HIV-associated cancer.

Gopal S, Achenbach CJ, Yanik EL, Dittmer DP, Eron JJ, Engels EA.

J Clin Oncol. 2014 Mar 20;32(9):876-80. doi: 10.1200/JCO.2013.53.1376. Epub 2014 Feb 18. No abstract available.

34.

HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.

Achenbach CJ, Buchanan AL, Cole SR, Hou L, Mugavero MJ, Crane HM, Moore RD, Haubrich RH, Gopal S, Eron JJ, Hunt PW, Rodriguez B, Mayer K, Saag MS, Kitahata MM; Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS).

Clin Infect Dis. 2014 Jun;58(11):1599-606. doi: 10.1093/cid/ciu076. Epub 2014 Feb 12.

35.

HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study.

Gach JS, Achenbach CJ, Chromikova V, Berzins B, Lambert N, Landucci G, Forthal DN, Katlama C, Jung BH, Murphy RL.

PLoS One. 2014 Jan 15;9(1):e85371. doi: 10.1371/journal.pone.0085371. eCollection 2014.

36.

Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.

Gopal S, Patel MR, Yanik EL, Cole SR, Achenbach CJ, Napravnik S, Burkholder GA, Reid EG, Rodriguez B, Deeks SG, Mayer KH, Moore RD, Kitahata MM, Eron JJ, Richards KL.

J Natl Cancer Inst. 2013 Aug 21;105(16):1221-9. doi: 10.1093/jnci/djt158. Epub 2013 Jul 26.

37.

Association of early HIV viremia with mortality after HIV-associated lymphoma.

Gopal S, Patel MR, Yanik EL, Cole SR, Achenbach CJ, Napravnik S, Burkholder GA, Reid EG, Rodriguez B, Deeks SG, Mayer KH, Moore RD, Kitahata MM, Richards KL, Eron JJ.

AIDS. 2013 Sep 24;27(15):2365-73. doi: 10.1097/QAD.0b013e3283635232.

38.

Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.

Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Olshan A, Dittmer DP, Kitahata MM, Mugavero MJ, Saag M, Moore RD, Mayer K, Mathews WC, Hunt PW, Rodriguez B, Eron JJ.

Clin Infect Dis. 2013 Sep;57(5):756-64. doi: 10.1093/cid/cit369. Epub 2013 Jun 4.

39.

Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study.

Akanbi MO, Achenbach CJ, Feinglass J, Taiwo B, Onu A, Pho MT, Agbaji O, Kanki P, Murphy RL.

AIDS Res Hum Retroviruses. 2013 Jun;29(6):931-7. doi: 10.1089/AID.2012.0231. Epub 2013 Feb 25.

40.

Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection.

Achenbach CJ, Harrington RD, Dhanireddy S, Crane HM, Casper C, Kitahata MM.

Clin Infect Dis. 2012 Feb 1;54(3):424-33. doi: 10.1093/cid/cir802. Epub 2011 Nov 17.

41.

Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults.

Achenbach CJ, Darin KM, Murphy RL, Katlama C.

Future Virol. 2011 Feb;6(2):157-177.

42.

Age at cancer diagnosis among persons with AIDS.

Kitahata MM, Achenbach CJ, Saag MS.

Ann Intern Med. 2011 May 3;154(9):642-3; author reply 643. doi: 10.7326/0003-4819-154-9-201105030-00013. No abstract available.

PMID:
21536942
43.

Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.

Achenbach CJ, Cole SR, Kitahata MM, Casper C, Willig JH, Mugavero MJ, Saag MS.

AIDS. 2011 Mar 13;25(5):691-700. doi: 10.1097/QAD.0b013e3283437f77.

44.

Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.

Achenbach CJ, Scarsi KK, Murphy RL.

Adv Ther. 2010 Jan;27(1):1-16. doi: 10.1007/s12325-010-0006-9. Epub 2010 Mar 5. Review. Erratum in: Adv Ther. 2010 Feb;27(2):127.

45.

Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA.

Achenbach CJ, Till M, Palella FJ, Knoll MD, Terp SM, Kalnins AU, Murphy RL.

HIV Med. 2005 Jan;6(1):7-12.

Supplemental Content

Loading ...
Support Center